Eulexin
NDC Package 0085-0525-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Eulexin is a . Marketed by Merck Sharp & Dohme Corp., this product is identified by NDC 0085-0525 and is authorized under FDA application NDA018554.

Identification & Billing

NDC Package Code
0085-0525-06
Package Description
180 CAPSULE in 1 BOTTLE
Product Code
0085-0525
11-Digit Billing Format
00085052506

Clinical Specifications

Proprietary Name
Eulexin
Dosage Form
-

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Corp.
FDA Application #
NDA018554
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-27-1989
End Marketing Date
09-30-2005
Listing Expiration
09-30-2005
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0085-0525). Click a package code to view its specific billing and regulatory data.

0085-0525-03
100 CAPSULE in 1 PACKAGE
0085-0525-05
500 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0085-0525-06 identifies a specific commercial package of 180 capsule in 1 bottle of Eulexin, labeled by Merck Sharp & Dohme Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Merck Sharp & Dohme Corp. on January 27, 1989. The current certification is valid through September 30, 2005.

How is this Merck Sharp & Dohme Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00085052506. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0085-0525-06
11-Digit CMS (5-4-2)
00085-0525-06

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.